UNI-EN 198:Notification on the terms and conditions for distribution of the dividend
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 198 | / | 2023 | |||||||
| Date of issue: | 2023-11-24 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification on the terms and conditions for distribution of the dividend | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| “Sopharma” AD (the Company) notifies all shareholders of the Company about the decision of the EGM of “Sopharma” AD that took place on November 24, 2023 regarding the amount and type of dividend distributed and the terms and conditions for its distribution: The EGM approves the proposal by the Board of Directors for the distribution of 6-month gross dividend amounting to BGN 0.90 (ninety stotinki) per share. The persons eligible for dividend are those present in the register of the Central Depository 14 days after the day of the EGM on which the financial statements of the Company for the first half of 2023 was approved and the decision for dividend was taken, namely December 8 2023 (record date) – ex dividend date December 7 2023. The starting date for dividend payment is January 22 2024. In accordance with the Regulations of the Central Depository, the dividend shall be paid out as follows: for shareholders with client accounts at an investment intermediary – through the investment intermediary, for shareholders without accounts at an investment intermediary - through the branches of “Eurobank EFG – Bulgaria” AD /Postbank/ in the country. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Notification_dividend_2023_espi.pdf Notification_dividend_2023_espi.pdf | Notification on the terms and conditions for distribution of the dividend | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-11-24 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 16.4 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
